NEJM:复发性颈部脓肿的鳃裂窦-病例报道

2018-02-08 xing.T MedSci原创

脓肿是由于鳃裂残留物造成的鼻窦。鳃裂异常是由于鳃器官发育异常,为头颈部胚胎起源。第三和第四鳃弓的异常在影像上难以区分。根据咽窦的开放情况及其与喉上神经的关系,可以通过进行直接喉镜来予以区分:第四鳃弓的异常窦道向下,第三鳃弓的异常窦道向上。

患者为一名24岁男性,因脖子左侧肿胀和发烧2天而到耳鼻喉科就诊。该患者既往2年和6年前分别出现过类似的颈部脓肿,曾接受过抗生素和切口引流术。

临床检查显示甲状软骨水平直径2厘米的肿胀(如图A所示)。钡剂食管造影和互补计算机断层显像显示存在从左甲状腺上叶区域延伸至颈部脓肿的窦道(如图B箭头所示)。



脓肿是由于鳃裂残留物造成的鼻窦。鳃裂异常是由于鳃器官发育异常,为头颈部胚胎起源。第三和第四鳃弓的异常在影像上难以区分。根据咽窦的开放情况及其与喉上神经的关系,可以通过进行直接喉镜来予以区分:第四鳃弓的异常窦道向下,第三鳃弓的异常窦道向上。

该病的治疗包括抗生素控制感染和手术切除予以确诊。该患者接受了切口引流并服用抗生素治疗。计划进行直接喉镜检查和切除窦道,但该患者失访。

原始出处:


Chin-Yee Lau,et al. Branchial-Cleft Sinus Manifesting as Recurrent Neck Abscess.N Engl J Med 2018.http://www.nejm.org/doi/full/10.1056/NEJMicm1710539?query=recirc_top_ribbon_article_4

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1909700, encodeId=34e81909e00b9, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Jun 11 08:23:00 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537256, encodeId=1561153e25611, content=<a href='/topic/show?id=8a988520e74' target=_blank style='color:#2F92EE;'>#脓肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85207, encryptionId=8a988520e74, topicName=脓肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01712842068, createdName=hunizi009, createdTime=Sat Feb 10 01:23:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589750, encodeId=7c7e1589e5014, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Sat Feb 10 01:23:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286223, encodeId=bc2328622347, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Feb 08 11:43:52 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1909700, encodeId=34e81909e00b9, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Jun 11 08:23:00 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537256, encodeId=1561153e25611, content=<a href='/topic/show?id=8a988520e74' target=_blank style='color:#2F92EE;'>#脓肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85207, encryptionId=8a988520e74, topicName=脓肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01712842068, createdName=hunizi009, createdTime=Sat Feb 10 01:23:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589750, encodeId=7c7e1589e5014, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Sat Feb 10 01:23:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286223, encodeId=bc2328622347, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Feb 08 11:43:52 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
    2018-02-10 hunizi009
  3. [GetPortalCommentsPageByObjectIdResponse(id=1909700, encodeId=34e81909e00b9, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Jun 11 08:23:00 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537256, encodeId=1561153e25611, content=<a href='/topic/show?id=8a988520e74' target=_blank style='color:#2F92EE;'>#脓肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85207, encryptionId=8a988520e74, topicName=脓肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01712842068, createdName=hunizi009, createdTime=Sat Feb 10 01:23:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589750, encodeId=7c7e1589e5014, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Sat Feb 10 01:23:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286223, encodeId=bc2328622347, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Feb 08 11:43:52 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1909700, encodeId=34e81909e00b9, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42518, encryptionId=8f1f42518d8, topicName=复发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Mon Jun 11 08:23:00 CST 2018, time=2018-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537256, encodeId=1561153e25611, content=<a href='/topic/show?id=8a988520e74' target=_blank style='color:#2F92EE;'>#脓肿#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85207, encryptionId=8a988520e74, topicName=脓肿)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d01712842068, createdName=hunizi009, createdTime=Sat Feb 10 01:23:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1589750, encodeId=7c7e1589e5014, content=<a href='/topic/show?id=124d10065220' target=_blank style='color:#2F92EE;'>#颈部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100652, encryptionId=124d10065220, topicName=颈部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c46a17776631, createdName=木头人519, createdTime=Sat Feb 10 01:23:00 CST 2018, time=2018-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=286223, encodeId=bc2328622347, content=学习了.涨知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Thu Feb 08 11:43:52 CST 2018, time=2018-02-08, status=1, ipAttribution=)]
    2018-02-08 1ddf0692m34(暂无匿称)

    学习了.涨知识

    0

相关资讯

Oncology Letters:不同复发风险肝转移患者的化疗反应与手术切除的预后

手术切除是结直肠癌肝转移(CRLM)患者获得长期生存的主要手段,但手术切除后约70%的患者会发生复发。新辅助化疗是降低复发,延长无复发生存的重要手段。

Stroke:颈动脉壁体积进展与复发性短暂性脑缺血发作或卒中的相关性分析!

由此可见,颈动脉壁体积的年度进展与复发性缺血性脑血管事件独立相关,这种指标增加了对斑块内出血和纤维帽破裂的事件预测价值。

JCO:ASPIRE研究:KRd方案治疗复发/难治多发性骨髓瘤的疗效如何?

美国约翰塞尔癌症中心的Siegel教授等开展了一项随机、多中心、III期临床研究(ASPIRE研究),旨在探讨KRd方案在RRMM治疗中的疗效及安全性。其文章发表在近期的JCO杂志上。

Neurology:多发性硬化妇女妊娠期间复发率分析!

由此可见,妊娠期MS复发率高于之前公布的复发率。妊娠前使用长洗脱期的高效治疗药物会增加妊娠期间MS复发的风险。产后MS复发发生率与之前报告相似。

ANN ONCOL:Pembrolizumab治疗复发性生殖细胞肿瘤

尽管对于复发性生殖细胞肿瘤患者可以进行标准剂量或大剂量挽救性化疗,仍有约15%的患者是无法治愈的。免疫检查点抑制剂在多种肿瘤中均具有抗肿瘤活性。ANN ONCOL近期发表了一篇文章,报道了第一个生殖细胞肿瘤患者应用免疫治疗的临床研究

J Thromb Haemost:轻度抗凝血酶缺乏症与复发性静脉血栓栓塞风险!

由此可见,该研究证实了轻度抗凝血酶缺乏是复发性VTE的危险因素。